3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
34
Neoplasm Metastasis
3
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2
Metastatic Castration-resistant Prostate Cancer
2
Adenocarcinoma
2
Urologic Diseases
1
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Radiation Injuries
1
Prostatic Diseases
1
Prostate Cancer Metastatic
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oligometastatic Prostate Cancer
1
Neoplasm Recurrence, Local
1
Metastatic Hormone Sensitive Prostate Cancer
1
Metastatic Castrate-sensitive Prostate Cancer
1
Hormone Sensitive Prostate Cancer
1
Genital Neoplasms, Male
1
Gastrointestinal Diseases
1
Erectile Dysfunction
1
Breast Neoplasms
1
Interventions
gedatolisib
1
gallium 68 PSMA-11
1
darolutamide
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
(225)Ac-PSMA-617
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Genital Diseases, Male
×
Androgen Antagonists
×
90 days
×
Clear all
No trials found.